HealOps vs Traversal: AI SRE Comparison (2026)

HealOps and Traversal are both agentic SREs that evaluate many hypotheses in parallel and keep a human in control rather than auto-deploying. Traversal’s causal-inference engine is genuinely excellent at root-cause analysis. The differences are not residency — both are read-only with no vendor data lake — but the remediation artifact and accessibility: HealOps ships a reviewed pull request with a regression test attached, while Traversal is RCA-first with human-gated, whitelisted operations and is enterprise-only and demo-led.

To be explicit up front: data residency is a peer feature in this comparison, so we don’t claim it as the wedge against Traversal. The real axes are the tested-PR artifact and who can adopt the tool. Where marketing and verifiable reality diverge, we say so.

At a glance

Capability	HealOps	Traversal
Autonomous root-cause investigation	✓	✓ (causal inference)
Parallel hypothesis testing	✓	✓ (thousands in parallel)
Ships fix as a reviewed pull request	✓	Partial (UI suggests/proposes; autonomous PR unverified)
Regression test attached to the fix	✓	✕
Never auto-deploys (human merges/approves)	✓	✓ (button-press on ~50 whitelisted commands)
Read-only · no vendor data lake	✓	✓ (on-prem / BYOC supported) — peer
Learns / authors runbooks	✓ (portable runbooks)	Partial
Handles mainframe / on-prem / legacy	Partial	✓
Accessibility	Private beta, not enterprise-only	Enterprise-only, demo-led
Scope	General infra	General / enterprise + legacy

What Traversal does well

Traversal — “the AI SRE for the enterprise” — is built by a team of causal-inference and causal-ML academics, and that research depth is its real strength. Publicly available information points to roughly $48M raised across Seed and Series A on coming out of stealth in June 2025 (Sequoia and Kleiner Perkins), plus a strategic investment from Amex Ventures in March 2026.

The core technology is a “Production World Model” and a “Causal Search Engine” that evaluate thousands of hypotheses in parallel. Traversal reports high accuracy — over 90% RCA accuracy when the cause is present in the data — and a published Amex result of 82% RCA accuracy with a 32% MTTR reduction. It is built for hard enterprise environments, including mainframe, on-prem and legacy systems, and supports on-prem and bring-your-own-cloud deployment with no vendor data lake.

If you run a large, heterogeneous enterprise estate and want best-in-class causal root-cause analysis with strong residency, Traversal is a serious, credible option.

Where HealOps differs

Both tools share the investigation engine’s shape — see what is an AI SRE — and both keep a human in control. The differences are downstream of the diagnosis.

The remediation artifact: a reviewed PR with a regression test. This is the central distinction. Traversal is RCA-first; its remediation is human-gated execution of whitelisted operations — roughly fifty approved commands, with the CEO stating plainly that “you have to press a button.” Its UI can suggest or propose pull requests, but autonomous open-and-merge of PRs appears unverified or overstated relative to marketing language about “self-healing,” and there is no evidence of a regression test attached. HealOps’s core motion is different: it opens a reviewed pull request on the offending repo with a minimal diff, an evidence-linked RCA, and a regression test that reproduces the incident — failing before the change, passing after. That tested-diff artifact is the part almost no competitor ships, and it’s the whole argument in why your AI SRE should open a pull request, not deploy to prod.

The difference is code versus ops actions. Whitelisted operations resolve incidents by executing approved runtime commands; a HealOps PR fixes the underlying cause in source code, with a test that proves it and guards against regression — the difference between shipping the diff that closes the page, not deploying it.

Accessibility. As of writing, Traversal is enterprise-only, demo-led, with no public pricing. HealOps is in private beta and built to be adoptable beyond enterprise-only deals, so a platform team can run the fix-shipping loop without a top-down enterprise procurement cycle.

Portable runbooks. HealOps promotes each verified fix into a human-owned runbook entry and a continuous regression check, keeping the learned knowledge inspectable and portable.

On data residency the two are genuine peers — both read-only, both with no vendor data lake, and Traversal supports on-prem/BYOC. HealOps’s own posture of keeping your logs in your cloud matches that bar rather than beating it, so we differentiate on the artifact and accessibility, not on residency.

Which should you choose?

Pick Traversal if you run a large, heterogeneous enterprise estate — including mainframe, on-prem or legacy systems — and want best-in-class causal root-cause analysis with strong residency and human-gated, whitelisted operations, and you’re comfortable with an enterprise-only, demo-led engagement.

Pick HealOps if you want the remediation artifact to be a reviewed pull request with a regression test attached — a fix in source code, proven and guarded — rather than execution of whitelisted ops, and you want a tool you can adopt without an enterprise-only sales motion.

Both refuse to auto-deploy, which is the right posture for production. For the wider field — including Resolve AI, Cleric and incident.io — see the best AI SRE tools in 2026, or compare with the best-funded pure-play in HealOps vs Resolve AI.